NewsBlog: [Entry posted at 9th May 2008 10:54 PM GMT] BrainCells, a company that stakes its existence on the once-heretical notion of adult neurogenesis, is finally taking its novel treatment for depression into a phase II trial, CEO Jim Schoeneck told me at a neurotechnology meeting in Boston yesterday (May 8).
Researchers have recently begun to suspect that treating depression requires neurogenesis. Drugs such as Prozac, though, stimulate nerve growth via the serotonin pathway, which... Click to continue
|
Comment on this blog
NewsBlog: [Entry posted at 9th May 2008 10:49 PM GMT] The third annual Neurotech Industry meeting in Boston kicked off yesterday morning (May 8) with some big numbers:
- Two billion people each year are affected by brain-related illnesses, from stroke to depression to chronic pain, with an economic loss worldwide of about $2 trillion.
- Venture capital companies invested about $1.77 billion in neuroscience-related research last year.
- Worldwide, neuro-related industry profits hit $130.5 billion in 2007-- a growth of 8% from the previous... Click to continue
|
Comment on this blog
NewsBlog: [Entry posted at 8th May 2008 07:08 PM GMT] Microbes may have the capacity for a type of learning generally attributed to higher organisms, suggests a paper published online in Science today (May 8).
"We have to start to think about bacterial behavior in a more sophisticated way," said Saeed Tavazoie of Princeton University, who led the study.
Researchers have long assumed that microbes respond to... Click to continue
|
Comment on this blog
|
Alla's blog
Alla Katsnelson
Location:
Philadelphia, USA
Who am I?
Associate Editor
Previous months
>> May 2008
>> April 2008
>> March 2008
>> February 2008
>> January 2008
>> December 2007
>> November 2007
>> October 2007
>> September 2007
>> August 2007
|
